Thermo Fisher Scientific (TMO) Tops Q1 EPS by 40c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- SanDisk shares fall on election and chip sector pressure
- Seagate Technology shares drop amid sector selloff
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank
April 25, 2024 6:16 AM EDTDeutsche Bank analyst Justin Bowers raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $610.00 (from $600.00) while maintaining a Buy rating.
The analyst comments "Messaging around bioprocessing was concise but positive, as order growth and book-to-bill continue to trend higher. We are... More
Thermo Fisher Scientific (TMO) lifts guidance after topping Q1 expectations
April 24, 2024 6:13 AM EDTThermo Fisher Scientific (NYSE: TMO) shares rose 3.55% after the company reported first-quarter earnings and revenue that exceeded Wall Street's expectations. The company's adjusted earnings per share (EPS) came in at $5.11, surpassing the analyst estimate of $4.71. Revenue for the quarter also beat consensus estimates, reaching $10.34 billion against expectations of $10.16 billion.
The science-serving leader saw a slight decline in revenue compared to the... More



